16 completed. 16 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 16 | Completed 16 |
Follow Diabetes Type 2: new trials by email Literature Review of Diabetes Type 2 trials Research Report on Diabetes Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus Semaglutide - Psoriasis Vulgaris, Diabetes Type 2 | Phase 4 | Completed | University of Banja Luka | 30 | 2023-05-03 | 2024-07-01 |
| Baseline Oral Health Study: UnCoVer the Connections to General Health Subgingival chlorhexidine irrigation, Dental Supplies, Periodonal Treatment - Cardiovascular Diseases, Diabetes Type 2 | Phase 4 | Completed | University of North Carolina, Chapel Hill | 786 | 2021-09-28 | 2026-02-12 |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults Biological samples - Kidney Transplant, Myeloma | Phase 4 | Completed | Centre Hospitalier Régional d'Orléans | 196 | 2021-03-26 | 2025-12-23 |
| Follow-up of NAFLD Patients With MRI-PDFF Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG - Diabetes Type 2, NAFLD | Phase 4 | Completed | Asmaa Abdelfattah Elsayed | 80 | 2020-12-01 | 2022-12-20 |
| High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy Vitamin D - Diabetes Type 2, Diabetic Neuropathies | Phase 4 | Completed | Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 68 | 2018-01-10 | 2020-05-06 |
| MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis Prolia, 60 Mg/mL Subcutaneous Solution, Teriparatide - Postmenopausal Osteoporosis, Diabetes Type 2 | Phase 4 | Completed | Medical University of Vienna | 26 | 2017-03-01 | 2023-01-26 |
| Mineralocorticoid Receptor Antagonists in Type 2 Diabetes Eplerenone, Placebo - Diabetes Type 2 | Phase 4 | Completed | Herlev Hospital | 140 | 2015-11-01 | 2018-06-01 |
| Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes pomegranate juice, lifestyle modification - Diabetes Type 2 | Phase 4 | Completed | National Nutrition and Food Technology Institute | 60 | 2014-11-01 | 2015-09-24 |
| Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan Insulin treatment during Ramadan, Standard of care - Diabetes Type 2, Treatment During Ramadan | Phase 4 | Completed | Meir Medical Center | 245 | 2011-09-01 | 2013-04-12 |
| Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients BIAsp 30, NPH/Reg - Diabetes Type 2 | Phase 4 | Completed | Tehran University of Medical Sciences | 160 | 2011-07-01 | 2013-06-28 |
| Evaluation of Block Duration in Type 2 Diabetes Patients ropivacaine - Diabetes Type 2 | Phase 4 | Completed | Pierre and Marie Curie University | 70 | 2011-07-01 | 2012-12-24 |
| Type 2 Diabetes and Ambulatory Surgery Patients Metformin continue, Metformin discontinue - Diabetes Type 2 | Phase 4 | Completed | University of Texas Southwestern Medical Center | 160 | 2010-03-22 | 2017-06-12 |
| Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Insulin Detemir; Insulin Insulatard, Insulin Detemir, Insulin Insulatard - Diabetes Type 2, Weight Gain | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 24 | 2008-06-01 | 2010-01-20 |
| Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment Insulin-Levemir, Exenatide-Bayetta, Insulin-Levemir and Exenatide-Bayetta - Diabetes Type 2 | Phase 4 | Completed | Novo Nordisk A/S | 75 | 2008-04-01 | 2011-06-27 |
| Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine Insulin Glargine - Diabetes Type 2 | Phase 4 | Completed | Sanofi | 26 | 2005-10-01 | 2009-12-07 |
| The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle Pioglitazone, placebo - Diabetes Type 2 | Phase 4 | Completed | East Tennessee State University | 12 | 2002-03-01 | 2013-02-27 |
Diabetes Mellitus, Type 2 (16) · Diabetes Mellitus (3) · Acquired Immunodeficiency Syndrome (1) · Bites and Stings (1) · Cardiovascular Diseases (1) · Diabetic Neuropathies (1) · Fasting (1) · Hematologic Neoplasms (1) · Hypergammaglobulinemia (1) · Hypernatremia (1) · Multiple Sclerosis (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Non-alcoholic Fatty Liver Disease (1) · Osteoporosis, Postmenopausal (1)
Endocrine System Diseases (16) · Glucose Metabolism Disorders (16) · Metabolic Diseases (16) · Nutritional and Metabolic Diseases (16) · Diabetes Mellitus (13) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Avitaminosis (1) · Behavior (1) · Blood Protein Disorders (1) · Blood-Borne Infections (1) · Body Weight (1)
Insulin Detemir (2) · Continuous Glucose Monitoring (1) · Denosumab (1) · Eplerenone (1) · Exenatide (1) · Insulin Glargine (1) · Metformin (1) · Pentoxifylline (1) · Pioglitazone (1) · Ropivacaine (1) · Standard of Care (1) · Sugars (1) · Teriparatide (1) · Ursodeoxycholic Acid (1) · Vitamin D (1)
Asmaa Abdelfattah Elsayed (1) · Centre Hospitalier Régional d'Orléans (1) · Copenhagen University Hospital, Rigshospitalet (1) · East Tennessee State University (1) · Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (1) · Herlev Hospital (1) · Medical University of Vienna (1) · Meir Medical Center (1) · National Nutrition and Food Technology Institute (1) · Novo Nordisk A/S (1) · Pierre and Marie Curie University (1) · Sanofi (1) · Tehran University of Medical Sciences (1) · University of Banja Luka (1) · University of North Carolina, Chapel Hill (1)
United States (3) · Denmark (2) · France (2) · Iran (2) · Austria (1) · Bosnia and Herzegovina (1) · Egypt (1) · Israel (1) · Russia (1) · Sweden (1)
Alireza Esteghamati, M.D. (1) · Asmaa A Elsayed, PhD (1) · Charles A Stuart, MD (1) · Jelena Petkovic-Dabic (1) · Margareta Olsson-Birgersson (1) · Naim Shehadeh, MD (1) · Philippe Cuvillon, PhD (1) · Robert A Vigersky, MD (1) · Saroja Voruganti, PhD (1) · Tatiana Karonova, PhD (1) · Tonny Jensen, M.D MSci. (1)
PMID 17251278, PMID 22002075, PMID 23348203, PMID 26234442, PMID 29933267, PMID 30044293, PMID 33068776, PMID 34463640
2015 (1)